logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
R

Ran Tur‐Kaspa

Rabin Medical Center

39H指数
187论文数
5.1K被引数
收录论文 55
发表时间
logo
Beneficial Effect of Vitamin D on Non-Alcoholic Fatty Liver Disease (NAFLD) Progression in the Zebrafish Model维生素d对斑马鱼模型非酒精性脂肪性肝病 (NAFLD) 进展的有益作用
errNUTRIENTS
IF5
err2023-03-10
err3
errOAAI
errGrinberg, Lihi; Dabbah Assadi, Fadwa; Baum, Gideon; Zemel, Romy; Tur-Kaspa, Ran; Shochat, Chen; Karasik, David; Karpuj, Marcela V. V.
err分享
err收藏
Longitudinal kinetics of RBD plus antibodies in COVID-19 recovered patients over 14 months
errPLOS PATHOGENS
IF4.9
err2022-06-03
err7
errOAAI
errEyran, Tsuf; Vaisman-Mentesh, Anna; Taussig, David; Dror, Yael; Aizik, Ligal; Kigel, Aya; Rosenstein, Shai; Bahar, Yael; Ini, Dor; Tur-Kaspa, Ran; Kournos, Tatyana; Marcoviciu, Dana; Dicker, Dror; Wine, Yariv
err分享
err收藏
Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature
errSCIENTIFIC REPORTS
IF3.9
err2021-02-10
err25
errOAAI
errMunitz, Ariel; Edry-Botzer, L.; Itan, M.; Tur-Kaspa, R.; Dicker, D.; Marcoviciu, D.; Goren, M. G.; Mor, M.; Lev, S.; Gottesman, T.; Muhsen, K.; Cohen, D.; Stein, M.; Qimron, U.; Freund, N. T.; Wine, Y.; Gerlic, Motti
err分享
err收藏
Bevacizumab for the treatment of liver involvement in patients with hereditary hemorrhagic telangiectasia
errJOURNAL OF HEPATOLOGY
IF33
err2019-04-01
err0
PREAI
errIssachar, Assaf; Cohen-Naftaly, Michal; Arbib, Orly Sneh; Tur-Kaspa, Ran; Shlomai, Amir; Braun, Marius; Mei-Zahav, Meir
err分享
err收藏
Should we change the allocation policy for NASH patients?
errJOURNAL OF HEPATOLOGY
IF33
err2019-04-01
err0
PREAI
errIssachar, Assaf; Cohen-Naftaly, Michal; Arbib, Orly Sneh; Tur-Kaspa, Ran; Shlomai, Amir; Cohen, Sigal; Michowiz, Rachel; Mor, Eytan; Braun, Marius
err分享
err收藏
Teaching the Interplay Between Social Determinants of Health (SDH) and Health Outcomes: the ETGAR Student-Delivered Service
errJOURNAL OF GENERAL INTERNAL MEDICINE
IF4.2
err2019-03-11
err4
errOAAI
errSpitzer-Shohat, S.; Sagi, D.; Schuster, M.; Ben-Ami, M.; Rivo, M.; Tur-Kaspa, R.; Rudolf, M. C. J.
err分享
err收藏
Switching immunoglobulin base therapy to nucleoside/nucleotide analogues monotherapy is safe and effective as preventive therapy of reccurent HBV in liver transplanted patients-single centre experience
errJOURNAL OF HEPATOLOGY
IF33
err2018-04-01
err0
PREAI
errSneh, O.; Cohen-Naftaly, M.; Harif, Y.; Issachar, A.; Mor, E.; Tur-Kaspa, R.; Brown, M.
err分享
err收藏
TRANSCRIPTOMIC ANTAGONISM BETWEEN HCV INFECTION AND VITAMIN D
errJOURNAL OF HEPATOLOGY
IF33
err2016-01-01
err0
PREAI
errRapaport, N.; Zemel, R.; Morad, E.; Wynstein, D.; Karpuj, M.; Ravid, A.; Haviv, I.; Tur-Kaspa, R.
err分享
err收藏
AN INTERIM ANALYSIS OF A NATIONAL PROGRAM FOR TREATING HEPATITIS C WITH NOVEL ANTIVIRAL AGENTS
errJOURNAL OF HEPATOLOGY
IF33
err2016-01-01
err0
PREAI
errCohen, M.; Kahan, N. R.; Waitman, D. -A.; Tur-Kaspa, R.
err分享
err收藏
Viral hepatitis in older adults
errJOURNAL OF THE AMERICAN GERIATRICS SOCIETY
IF4.5
err2015-04-27
err28
PREAI
errMarcus, EL; TurKaspa, R
err分享
err收藏
Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients
errCOCHRANE DATABASE OF SYSTEMATIC REVIEWS
IF9.4
err2012-09-12
err10
PREAI
errKatz, Lior H.; Goldvaser, Hadar; Gafter-Gvili, Anat; Tur-Kaspa, Ran
err分享
err收藏
Vitamin D: An Innate Antiviral Agent Suppressing Hepatitis C Virus in Human Hepatocytes
errHEPATOLOGY
IF15.8
err2011-11-01
err164
PREAI
errGal-Tanamy, Meital; Bachmetov, Larisa; Ravid, Amiram; Koren, Ruth; Erman, Arie; Tur-Kaspa, Ran; Zemel, Romy
err分享
err收藏
VITAMIN-D ACTIVATES INNATE IMMUNITY AGAINST HCV AND INHIBITS VIRAL PRODUCTION
errJOURNAL OF HEPATOLOGY
IF33
err2011-03-01
err0
errOAAI
errBachmetov, L.; Gal-Tanamy, M.; Ravid, A.; Koren, R.; Erman, A.; Zemel, R.; Tur-Kaspa, R.
err分享
err收藏
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation
errCOCHRANE DATABASE OF SYSTEMATIC REVIEWS
IF9.4
err2010-07-07
err18
PREAI
errKatz, Lior H.; Tur-Kaspa, Ran; Guy, Daniel G.; Paul, Mical
err分享
err收藏
SINGLE-CHAIN ANTIBODIES INHIBIT HCV INFECTIOUS VIRUS REPLICATION BY PROTEIN DELIVERY
errJOURNAL OF HEPATOLOGY
IF33
err2010-04-01
err0
errOAAI
errGiterman-Galam, T.; Gal-Tanamy, M.; Bachmatov, L.; Yi, M.; Lemon, S. M.; Benhar, I.; Zemel, R.; Tur-Kaspa, R.
err分享
err收藏
INHIBITION OF HCV NS3 SERINE PROTEASE BY THE FLAVANOID QUERCETIN
errJOURNAL OF HEPATOLOGY
IF33
err2010-04-01
err0
errOAAI
errBachmetov, L.; Zemel, R.; Gal-Tanamy, M.; Vorobeychik, M.; Benhar, I.; Tur-Kaspa, R.
err分享
err收藏
Expression of liver-specific markers in naive adipose-derived mesenchymal stem cells
errLIVER INTERNATIONAL
IF5.2
err2009-09-03
err47
PREAI
errZemel, Romy; Bachmetov, Larisa; Ad-El, Dean; Abraham, Amir; Tur-Kaspa, Ran
err分享
err收藏
INHIBITION OF HCV CELL CULTURE INFECTIOUS VIRUS AND DRUG RESISTANT REPLICONS BY INTRABODIES
errJOURNAL OF HEPATOLOGY
IF33
err2009-04-01
err0
PREAI
errGal-Tanamy, M.; Zemel, R.; Bachmetov, L.; Jangra, R.; Villanueva, R.; Yi, M.; Lemon, S.; Benhar, I.; Tur-Kaspa, R.
err分享
err收藏
CHIMERIC PHENOTYPE OF MOUSE MESENCHYMAL STEM CELLS FROM ADIPOSE TISSUE AFTER HEPATOGENIC DIFFERENTIATION
errJOURNAL OF HEPATOLOGY
IF33
err2009-04-01
err0
errOAAI
errBachmetov, L.; Gitman, H.; Zemel, R.; Tur-Kaspa, R.
err分享
err收藏
Postshunt Hepatic Encephalopathy in Liver Transplant Recipients
errTRANSPLANTATION
IF5
err2009-03-15
err37
errOAAI
errBraun M, Marius; Bar-Nathan, Nathan; Shaharabani, Ezra; Aizner, Sigal; Tur-Kaspa, Ran; Belenky, Alexander; Mor, Eitan; Ben-Ari Z, Ziv
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
Z
Zobair M. Younossi
H 指数: 140 · 论文数: 1.5K
P
Patrick Marcellin
H 指数: 124 · 论文数: 1.0K
D
Dominique Valla
H 指数: 117 · 论文数: 830
D
Didier Samuel
H 指数: 112 · 论文数: 1.3K
T
Teri E. Klein
H 指数: 110 · 论文数: 506
查看更多